Aequus Pharmaceuticals Inc. Stock Price - AQSZF

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Aequus Pharmaceuticals Inc. AQSZF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.001004 -0.97% 0.102996 0.102996 0.102996 0.102996 0.104 09:51:38
Bid Price Ask Price Spread Spread % News
0.0951 0.1119 0.0169 15.09% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1 2,000 $ 0.102996 $ 206 29,510 0.0878 - 0.1847
Last Trade Time Type Quantity Stock Price Currency
09:51:38 2,000 $ 0.102996 USD

Aequus Pharmaceuticals Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 8.28M 80.44M $ -2.8M - -2.95 69.88M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aequus Pharmaceuticals Inc. News

Latest AQSZF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQSZF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.1070.1070.08780.096680027k11k-0.004004-3.74%
1 Month0.12870.1450.08780.1105500261k43k-0.025704-19.97%
3 Months0.15910.15910.08780.1254500261k36k-0.056104-35.26%
6 Months0.11460.18470.08780.1337500293k40k-0.011604-10.13%
1 Year0.17710.18470.08780.1375400293k33k-0.074104-41.84%
3 Years0.31510.3560.08780.197450339k41k-0.212104-67.31%
5 Years0.41090.56750.08780.205420339k39k-0.307904-74.93%

Aequus Pharmaceuticals Inc. Description

Aequus Pharmaceuticals Inc. is a Vancouver-based specialty pharmaceutical company focused on developing, advancing and promoting differentiated products in Canada. Aequus development pipeline focuses on enhancing delivery methods for approved drugs that are limited by non-compliance, high frequency dosing, first-pass metabolism side-effects, painful injections, or where the therapeutic profile can be improved by making an alternative delivery system available. Aequus is developing several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs within Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.

Your Recent History
Aequus Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.